Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001672132-16-000001
Filing Date
2016-04-14
Accepted
2016-04-14 14:40:29
Documents
1
Effectiveness Date
2016-04-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5558
  Complete submission text file 0001672132-16-000001.txt   6597
Mailing Address 15115 PARK ROW STE 100 HOUSTON TX 77084
Business Address 15115 PARK ROW STE 100 HOUSTON TX 77084 2813985656
Marlinz Pharma, LLC (Filer) CIK: 0001672132 (see all company filings)

EIN.: 812117610 | State of Incorp.: TX | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-261363 | Film No.: 161571433